Your browser doesn't support javascript.
loading
Outcomes Following Radiofrequency Renal Denervation According to Antihypertensive Medications: Subgroup Analysis of the Global SYMPLICITY Registry DEFINE.
Mahfoud, Felix; Mancia, Giuseppe; Schmieder, Roland E; Ruilope, Luis; Narkiewicz, Krzysztof; Schlaich, Markus; Williams, Bryan; Ribichini, Flavio; Weil, Joachim; Almerri, Khaled; Sharif, Faisal; Lauder, Lucas; Wanten, Marianne; Fahy, Martin; Böhm, Michael.
Afiliação
  • Mahfoud F; Saarland University Hospital, Homburg, Germany (F.M., L.L., M.B.).
  • Mancia G; University of Milano-Bicocca, Italy (G.M.).
  • Schmieder RE; University Hospital Erlangen, Germany (R.E.S.).
  • Ruilope L; Hospital Universitario 12 de Octubre and CIBERCV and School of Doctoral Studies and Research, Universidad Europea de Madrid, Spain (L.R.).
  • Narkiewicz K; Medical University of Gdansk, Poland (K.N.).
  • Schlaich M; Dobney Hypertension Centre, Medical School-Royal Perth Hospital Unit, The University of Western Australia (M.S.).
  • Williams B; University College London and National Institute for Health Research University College London Hospitals Biomedical Research Centre, United Kingdom (B.W.).
  • Ribichini F; Azienda Ospedaliera Universitaria Integrata Verona, Italy (F.R.).
  • Weil J; Sana Kliniken Lübeck GmbH, Germany (J.W.).
  • Almerri K; Chest Disease Hospital, Kuwait (K.A.).
  • Sharif F; University Hospital Galway and National University of Ireland Galway (F.S.).
  • Lauder L; Saarland University Hospital, Homburg, Germany (F.M., L.L., M.B.).
  • Wanten M; Medtronic PLC, Santa Rosa, CA (M.W., M.F.).
  • Fahy M; Medtronic PLC, Santa Rosa, CA (M.W., M.F.).
  • Böhm M; Saarland University Hospital, Homburg, Germany (F.M., L.L., M.B.).
Hypertension ; 80(8): 1759-1770, 2023 08.
Article em En | MEDLINE | ID: mdl-37317866
BACKGROUND: The Global SYMPLICITY Registry DEFINE (Denervation Findings in Real World) investigates radiofrequency renal denervation (RDN) in a broad range of patients with hypertension. We evaluated whether the number or type of antihypertensive medications were associated with increased long-term blood pressure (BP) reductions and cardiovascular outcomes following radiofrequency RDN. METHODS: Patients underwent radiofrequency RDN and were categorized by baseline number (0-3 and ≥4) and different combinations of medication classes. BP changes were compared between groups through 36 months. Individual and composite major adverse cardiovascular events were analyzed. RESULTS: Of 2746 evaluable patients, 18% were prescribed 0 to 3 and 82% prescribed ≥4 classes. At 36 months, office systolic BP significantly decreased (P<0.0001) by -19.0±28.3 and -16.2±28.6 mm Hg in the 0 to 3 and ≥4 class groups, respectively. Twenty-four-hour mean systolic BP significantly decreased (P<0.0001) by -10.7±19.7 and -8.9±20.5 mm Hg, respectively. BP reduction was similar between the medication subgroups. Antihypertensive medication classes decreased from 4.6±1.4 to 4.3±1.5 (P<0.0001). Most decreased (31%) or had no changes (47%) to the number of medications, while 22% increased. The number of baseline antihypertensive medication classes was inversely related to the change in prescribed classes at 36 months (P<0.001). Cardiovascular event rates were generally low. More patients in the ≥4 compared with 0 to 3 medication classes had myocardial infarction at 36 months (2.8% versus 0.3%; P=0.009). CONCLUSIONS: Radiofrequency RDN reduced BP safely through 36 months, independent of the number and type of baseline antihypertensive medication classes. More patients decreased than increased their number of medications. Radiofrequency RDN is a safe and effective adjunctive therapy regardless of antihypertensive medication regimen. REGISTRATION: URL: https://www. CLINICALTRIALS: gov; Unique identifier: NCT01534299.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hipertensão / Anti-Hipertensivos Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Hypertension Ano de publicação: 2023 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hipertensão / Anti-Hipertensivos Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Hypertension Ano de publicação: 2023 Tipo de documento: Article País de publicação: Estados Unidos